Edwards Lifesciences Financial Statements (EW)

Edwards Lifesciencessmart-lab.ru   2022 2022 2023 2024 2025   LTM ?
Report date 31.12.2022 13.02.2023 12.02.2024 28.02.2025 25.02.2026   25.02.2026
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 5 382 5 382 5 010 5 440 6 068   6 068
Operating Income, bln rub 1 749 1 702 1 427 1 379 1 636   1 621
EBITDA, bln rub ? 1 784 1 960 1 535 1 723 1 430   1 391
Net profit, bln rub ? 1 522 1 522 1 402 4 175 1 074   1 070
OCF, bln rub ? 1 218 895.8 542.3 1 595   1 595
CAPEX, bln rub ? 264.8 266.3 252.4 260.2   260.2
FCF, bln rub ? 953.4 629.5 289.9 1 335   1 335
Dividend payout, bln rub 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 2 513 2 513 2 545 2 943 3 105   3 118
Cost of production, bln rub 1 080 1 167 1 037 1 118 1 327   1 330
R&D, bln rub 945.2 945.2 962.9 1 053 1 079   1 079
Interest expenses, bln rub 16.3 26.2 17.6 19.8 0.000   0.000
Assets, bln rub 8 293 8 293 9 363 13 055 13 697   13 697
Net Assets, bln rub ? 5 807 5 807 6 650 9 998 10 338   10 338
Debt, bln rub 691.3 691.3 685.1 700.0 705.4   705.4
Cash, bln rub 1 215 1 215 1 633 3 976 4 227   4 227
Net debt, bln rub -524.0 -524.0 -947.7 -3 276 -3 521   -3 521
Ordinary share price, rub 74.6 74.6 76.3 74.0 85.3   83.2
Number of ordinary shares, mln 619.0 619.0 606.7 597.7 584.8   580.4
Market cap, bln rub 46 184 46 184 46 261 44 248 49 854   48 278
EV, bln rub ? 45 660 45 660 45 313 40 972 46 333   44 756
Book value, bln rub 4 357 4 357 5 106 7 045 7 441   7 441
EPS, rub ? 2.46 2.46 2.31 6.98 1.84   1.84
FCF/share, rub 0.00 1.54 1.04 0.49 2.28   2.30
BV/share, rub 7.04 7.04 8.42 11.8 12.7   12.8
EBITDA margin, % ? 33.1% 36.4% 30.6% 31.7% 23.6%   22.9%
Net margin, % ? 28.3% 28.3% 28.0% 76.7% 17.7%   17.6%
FCF yield, % ? 0.00% 2.06% 1.36% 0.66% 2.68%   2.77%
ROE, % ? 26.2% 26.2% 21.1% 41.8% 10.4%   10.4%
ROA, % ? 18.4% 18.4% 15.0% 32.0% 7.84%   7.81%
P/E ? 30.3 30.3 33.0 10.6 46.4   45.1
P/FCF 48.4 73.5 152.6 37.3   36.2
P/S ? 8.58 8.58 9.23 8.13 8.22   7.96
P/BV ? 10.6 10.6 9.06 6.28 6.70   6.49
EV/EBITDA ? 25.6 23.3 29.5 23.8 32.4   32.2
Debt/EBITDA -0.29 -0.27 -0.62 -1.90 -2.46   -2.53
R&D/CAPEX, % 356.9% 361.6% 417.2% 414.8%   414.8%
CAPEX/Revenue, % 0.00% 4.92% 5.32% 4.64% 4.29%   4.29%
Edwards Lifesciences shareholders